Skip to main content
Premium Trial:

Request an Annual Quote

Transgene, French Cancer Association ID'ing Targets for Cancer Biotherapies

NEW YORK (GenomeWeb News) – French biopharmaceutical firm Transgene today and the Ligue nationale contre le cancer, or the French league against cancer, today announced an agreement to identify membrane-specific targets from gene expression data in order to develop new oncology biotherapies.

The data was collected by Ligue from more than 4,800 tumors.

The Lique initiated a program in 2000 called Carte d'Identité des Tumeurs (CIT), or identity card of tumors, to analyze the genes and chromosomal alternations in several cancers in order to better diagnose disease and predict disease evolution. The program also hopes to improve the ability to predict response to therapy and to improve therapeutic follow-up.

CIT enables the identification of biomarkers associated with specific tumor-specific cellular mechanisms, and the Ligue and Transgene hope to accelerate the development of specific drugs for certain tumors, they said.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.